PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.55%
Positive revenue growth while EXP is negative. John Neff might see a notable competitive edge here.
-68.24%
Negative gross profit growth while EXP is at 5.17%. Joel Greenblatt would examine cost competitiveness or demand decline.
-91.94%
Negative EBIT growth while EXP is at 4.43%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-91.94%
Negative operating income growth while EXP is at 4.43%. Joel Greenblatt would press for urgent turnaround measures.
3.82%
Net income growth under 50% of EXP's 11.85%. Michael Burry would suspect the firm is falling well behind a key competitor.
2.17%
EPS growth under 50% of EXP's 13.68%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
2.17%
Diluted EPS growth under 50% of EXP's 13.79%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.35%
Slight or no buybacks while EXP is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.30%
Slight or no buyback while EXP is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
333.98%
10Y revenue/share CAGR at 75-90% of EXP's 422.51%. Bill Ackman would press for new markets or product lines to narrow the gap.
110.69%
5Y revenue/share CAGR similar to EXP's 118.55%. Walter Schloss might see both companies benefiting from the same mid-term trends.
91.60%
3Y revenue/share CAGR at 75-90% of EXP's 112.78%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
328.52%
Net income/share CAGR at 50-75% of EXP's 578.47%. Martin Whitman might question if the firm’s product or cost base lags behind.
244.12%
Below 50% of EXP's 517.77%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
270.44%
3Y net income/share CAGR similar to EXP's 297.70%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
63.86%
5Y equity/share CAGR 1.25-1.5x EXP's 44.14%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
50.79%
3Y equity/share CAGR above 1.5x EXP's 14.36%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.